Key result
Accumulation and immunoassay cross-reactivity of cardioinactive metabolites of digoxin caused false elevations in serum digoxin concentration in a patient with renal and hepatic dysfunction.
Case Report (n=1)
Combined renal and hepatic dysfunction can lead to false-positive digoxin measurements due to the accumulation of cardioinactive metabolites.
Answers are grounded in this paper and cite their sources.
Clinicians should interpret digoxin levels cautiously in combined renal-hepatic dysfunction; leaves open need for validated metabolite-specific assays.
A 41-year-old man with combined renal and hepatic dysfunction was noted to have marked elevations in serum digoxin concentration subsequent to the discontinuation of digoxin therapy. These elevations (peak value 8.6 ng/ml), as measured by both radioimmunoassay and fluorescence polarization immunoassay, were not associated with electrocardiographic evidence of digitalis toxicity. Using a combined high-performance liquid chromatography/radioimmunoassay, accumulation and immunoassay cross-reactivity of conjugates of digoxigenin monodigitoxoside (cardioinactive metabolites of digoxin) were found to be the basis of the observed false elevation in digoxin concentration.
No takes yet. Share an insight, caveat, or question.
Vlasses et al. (2008) conducted a case report in Combined renal and hepatic dysfunction (n=1). Digoxin measurement was evaluated on False elevation in digoxin concentration. Accumulation and immunoassay cross-reactivity of cardioinactive metabolites of digoxin caused false elevations in serum digoxin concentration in a patient with renal and hepatic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: